Monday, March 31, 2014

New Drug Targets for Treating Huntington's Disease

Improved walking and prolonged survival seen in a mouse model of Huntington's disease by tweaking a specific cell type's ability to absorb potassium in the brain, reports study published by UCLA, on March 30 in the online edition of emNature Neuroscience/em. The discovery could point to new drug targets for treating the devastating disease, which strikes one in every 20,000 Americans. Huntington's disease is passed from parent to child through a mutation in ...

Read More

No comments:

Post a Comment